CYTARABINE EBEWE

CYTARABINE

Public price

42,00 MAD

Reimbursement base

42,00 MAD

Active substance

CYTARABINE

Reimbursable

What is this medicine?

A cell cycle phase-specific antineoplastic agent and nucleoside metabolic inhibitor that acts primarily through the inhibition of DNA polymerase.

Verified summary

CYTARABINE, SOLUTION POUR PERFUSION, 100 MG, 1 FLACON 5 ML

Common uses

Treatment of newly diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC) in adults and pediatric patients 1 year and older.

Class

Nucleoside metabolic inhibitor

Availability note

Reimbursable

Hospital price

26,20 MAD

Strength

100 MG

Form

SOLUTION POUR PERFUSION

Presentation

1 FLACON 5 ML

Type

Therapeutic class

ANTINEOPLASIQUE CYTOTOXIQUE

This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.

Price history

Reference price recorded since 2017-12-18: 42,00 MAD

Available presentations and strengths